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Stress and exposure to glucocorticoids (GC) during early life render individuals vulnerable to
brain disorders by inducing structural and chemical alterations in specific neural substrates.
Here we show that adult rats that had been exposed to in utero GCs (iuGC) display increased
preference for opiates and ethanol, and are more responsive to the psychostimulatory actions
of morphine. These animals presented prominent changes in the nucleus accumbens (NAcc),
a key component of the mesolimbic reward circuitry; specifically, cell numbers and dopamine
(DA) levels were significantly reduced, whereas DA receptor 2 (Drd2) mRNA expression levels
were markedly upregulated in the NAcc. Interestingly, repeated morphine exposure signifi-
cantly downregulated Drd2 expression in iuGC-exposed animals, in parallel with increased
DNA methylation of the Drd2 gene. Administration of a therapeutic dose of L-dopa reverted
the hypodopaminergic state in the NAcc of iuGC animals, normalized Drd2 expression
and prevented morphine-induced hypermethylation of the Drd2 promoter. In addition, L-dopa
treatment promoted dendritic and synaptic plasticity in the NAcc and, importantly, reversed
drug-seeking behavior. These results reveal a new mechanism through which drug-seeking
behaviors may emerge and suggest that a brief and simple pharmacological intervention can
restrain these behaviors in vulnerable individuals.
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Introduction
Stressful events during critical developmental peri-
ods have long been considered as etiological factors in
psychiatric disorders such as schizophrenia, depres-
sion and drug-seeking behavior.1–4 The programming
effects of stress are most likely mediated by endogen-
ous glucocorticoids (GC), whose ability to produce
structural re-organization and dysfunction of the
neural substrates that underpin these stress-related
pathologies are well known.1,5–7 Although adminis-
tration of prenatal GC does not mimic prenatal stress,
synthetic GC such as dexamethasone (DEX) are
widely used in obstetrics, for example, to ensure
fetal lung maturation during late pregnancy in
humans.8 DEX is not biodegraded in the same way
as its naturally occurring congeners, and crosses the
maternal-placental barrier to a greater extent than
endogenous GC;9,10 it can thus pose additional risk for
the developing brain.
We previously demonstrated that fetal exposure to
GC leads to hyper-emotionality in adulthood.11 In
addition, we showed that prenatal DEX/GC targets
the mesolimbic dopaminergic system;12 this system
comprises projections from the ventral tegmental area
(VTA) to the nucleus accumbens (NAcc) and is
strongly implicated in motivational and reward
aspects of addictive behaviors.13–15 Specifically, the
NAcc of adult rats exposed to GC in utero (iuGC)
display reduced neuronal numbers and fewer dopa-
mine (DA) inputs from the VTA.12 Further, early life
stress is known to influence DA receptor expression
in the adult NAcc16,17 and changes associated
with increased behavioral responses to stress and
cocaine.1,4,18,19 Together, these observations suggest
that prenatal exposure to elevated levels of GC can
program the mesolimbic circuit. In the present study,
a multimodal analysis was used to further define the
molecular neurobiological mechanisms that underlie
the initiation and reversibility of drug-seeking beha-
vior by prenatal exposure to GC.
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Materials and methods
Animals and behavioral tests
Pregnant Wistar rats were individually housed under
standard laboratory conditions (light/dark cycle of 12/
12h with lights on at 08:00h; 22 1C); food and water
were provided ad libitum. Subcutaneous (s.c.) injec-
tions of DEX at 1mgkg1 (DEX; iuGC animals) or
saline (control) were administered on gestation days
18 and 19. All manipulations were done in accor-
dance with the local regulations (European Union
Directive 2010/63/EU) and NIH guidelines on animal
care and experimentation.
Male offspring (nX8) derived from four different
litters were subjected to behavioral tests when they
were 3–4 months old.
Open field
Locomotor behavior was investigated using the open-
field test. Briefly, rats were placed in the center of
an arena (MedAssociates, St Albans, VT, USA) and
their ambulation was monitored online over a period of
15min. Total distances traveled were used as indicators
of locomotor activity. Animals were injected with
saline or morphine and tested 30min after injection.
Conditioned place preference (CPP)
The place preference apparatus consisted of two
compartments with different patterns on floors and
walls, separated by a neutral area (MedAssociates).
Animals were placed in the central neutral area and
allowed to explore both compartments, allowing
definition of the preferred compartment (day 1).
During the conditioning phase (day 2–4), rats were
confined to the pre-test preferred compartment for
20min after saline injection (1ml kg1, s.c.) and, after
a 6-h gap, to the other compartment for 20min after
injection of morphine (10mgkg1, s.c.). CPP was
assessed on day 5 (20min) when all compartments
were accessible to the animal. Results are expressed
as the difference of time spent in the drug-paired to
saline-paired side.
Ethanol consumption
The two-bottle choice protocol was carried out for
15 days as described previously.20 Briefly, after 3 days
of taste habituation (one bottle with 10% ethanol
and other with 5% sucrose), rats were offered both
bottles. Each bottle was weighted daily; bottle posi-
tions were changed every day to control for position
preference. Corrections were made for daily evapora-
tion and spillage.
Cross-fostering and maternal behavior
For cross-fostering experiments, litters from five
control and five DEX-treated mothers were exchanged
on postnatal day 1. Maternal behavior was assessed
every second day, over a period of 30min. Both, pup-
directed (nursing, non-nutritive contact, licking
and nest building) and self-directed (self-grooming,
resting, vertical activity and carrying) behaviors were
registered.
Drugs
Morphine hydrochloride (Labesfal Pharmaceutical,
Campo de Besteiros, Portugal) was administered s.c.
at a dose of 10mgkg1; sesame oil was used as the
vehicle. L-dopa/carbidopa (Sinemet, Merck, NJ, USA)
at a dose of 36.0/9.0mg/kg (in water) was adminis-
tered daily by oral gavage.
Tyrosine hydroxylase (TH) immunohistochemistry
Animals were deeply anesthetized and transcardially
perfused with 4% paraformaldehyde. Cerebral hemi-
spheres were separated by a longitudinal cut in the
midsagittal plane. Sections of 30 mmwere treated with
3% H2O2 and blocked with 4% bovine serum albumin
in phosphate-buffered saline. Sections were then
incubated overnight at 4 1C with rabbit anti-TH serum
(1:2000; Affinity Reagents, CO, USA). Antigen visua-
lization was carried out by sequentially incubating
with biotinylated goat anti-rabbit antibody, ABC1
(Vector, Burlingame, CA, USA) and diaminobenzidine
(DAB, Sigma). The density of TH-positive fibers
impinging upon the NAcc was estimated as pre-
viously described.12
Structural analysis
Rats were transcardially perfused with 0.9% saline
under deep pentobarbital anesthesia and processed as
described previously.21 Briefly, brains were removed
and immersed in Golgi–Cox solution22 for 14 days;
brains were then transferred to a 30% sucrose
solution (7 days), before being cut on a vibratome.
Coronal sections (200mm thick) were collected and
blotted dry onto cleaned, gelatin-coated microscope
slides. They were subsequently alkalinized in 18.7%
ammonia, developed in Dektol (Kodak, Rochester,
NY, USA), fixed in Kodak Rapid Fix (prepared as per
package instructions with solution B omitted), dehy-
drated through a graded series of ethanols, cleared in
xylene, mounted and coverslipped. For each selected
neuron, all branches of the dendritic tree were
reconstructed at  600 magnification, using a motor-
ized microscope with oil objectives (Axioplan 2,
Carl Zeiss, Thornwood, NY, USA) that was attached
to a camera (DXC-390, Sony, Tokyo, Japan) and
Neurolucida software (Microbrightfield, Williston,
VT, USA). A 3D analysis of the reconstructed neurons
was performed using NeuroExplorer software (Micro-
brightfield). Twenty neurons were studied in each
animal, and results from the same animal were
averaged. To assess differences in the arrangement
of dendritic material, a 3D version of a Sholl
analysis23,24 was performed. For this, we counted
the number of intersections of dendrites with con-
centric spheres positioned at radial intervals of 20mm;
in addition, we also measured dendritic tree lengths
located between two consecutive spheres. The meth-
od for sampling dendritic branches for spine density
was designed as follows: only branches that (1) were
either parallel or at acute angles to the coronal surface
of the section and (2) did not show overlap with other
branches that would obscure visualization of spines
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were considered. Because treatment-induced changes
in the apical dendritic branches varied with distance
to soma, segments were randomly selected in the
proximal parts of the tree; selection of basal dendrite
was done at radial distances between 50 and 100 mm.
To assess treatment-induced changes in spine mor-
phology, spines in the selected segments were
classified according to Harris et al.25 in mushroom,
thin, wide and ramified categories. Thin spines were
considered immature, whereas the other spine types
were considered to be mature spines.
Macrodissection
Animals were anesthetized, decapitated, and heads
were immediately snap-frozen in liquid nitrogen.
Brain areas of interest were rapidly dissected on ice
under a stereomicroscope, observing anatomical land-
marks. Samples were snap-frozen (dry ice) and stored
at 80 1C until use.
Neurochemical evaluation
Levels of catecholamines were assayed by high-perfor-
mance liquid chromatography, combined with electro-
chemical detection (HPLC/EC) using a Gilson instru-
ment (Gilson, Middleton, WI, USA), fitted with an
analytical column (Supleco Supelcosil LC-18 3mM,
Bellefonte, PA, USA; flow rate: 1.0mlmin1). Samples
were stored overnight in 0.2N perchloric acid
at 20 1C, sonicated (5min on ice) and centrifuged at
5000 g. The resulting supernatant was filtered through
a Spin-X HPLC column (Costar, Lowell, MA, USA) to
remove debris and 150ml aliquots were injected into
the HPLC system, using a mobile phase of 0.7M
aqueous potassium phosphate (pH 3.0) in 10%
methanol, 1-heptanesulfonic acid (222mg l1) and
Na-EDTA (40mg l1). A standard curve using known
concentrations of all catecholamines was run each day.
Molecular analysis
For real-time PCR analysis, total RNA was isolated
using Trizol (Invitrogen, Carlsbad, CA, USA) and
DNase treated (Fermentas, Burlington, Canada) fol-
lowing recommended protocols. Two mg of RNA was
converted into cDNA using the iSCRIPT kit (Biorad,
Hercules, CA, USA). Reverse transcription PCR
was performed using Quantitec SyberGreen (Qiagen,
Venlo, The Netherlands) and the Biorad q-PCR CFX96
apparatus. Hprt was used as a housekeeping gene.
Relative quantification was used to determine fold
changes (control vs iuGC), using the DDCT method.
Primer sequences are shown in Supplementary Table 1.
For western blotting procedures, ice-cold lysis
buffer (50mM Tris-HCl pH 7.4, 50mM NaCl, 1mM
phenylmethylsulfonyl fluoride, complete protease
inhibitors (Roche, Basel, Switzerland)) was added to
each frozen area. After disruption of the tissue using a
23G needle, 0.1% SDS and 1% Triton X-100 was
added to each sample. After incubation on ice for 1h,
samples were centrifuged at 13 000 r.p.m. for 10min at
4 1C; the supernatant was quantified using the
Bradford method. Forty mg of total protein was loaded
into SDS-polyacrylamide gel electrophoresis and then
transferred to nitrocellulose membranes. After incu-
bation with the primary antibodies: rabbit anti-
Dopamine receptor D1 (1:2500, ab20066, Abcam,
Cambridge, UK), rabbit anti-Dopamine receptor
D2 (1:2000, ab21218, Abcam) and mouse anti-
alpha-tubulin (1:200, DSHB, Iowa, USA); the second-
ary antibodies were incubated at a 1:10 000 dilution
(Santa Cruz Biotechnologies, Santa Cruz, CA, USA).
Detection was done using ECL kit (Pierce, Rockford,
IL, USA). Band quantification was performed using
ImageJ (http://rsbweb.nih.gov/ij/) as advised by
the software manufacturers, using a-tubulin as the
loading control. At least six animals per group were
analyzed.
For epigenetic analysis, four animals per group
were analyzed. Genomic DNA of 2 mg were bisulfite-
converted (EZDNA Methylation Kit, Zymo Research,
Irvine, CA, USA) and amplified with primers CpG-
Drd2_F and CpG-Drd2_R (designed using Methpri-
mer), using AmplitaQ Gold (Applied Biosystems,
Carlsbad, CA, USA). Bands were purified using
innuPREP Gel extraction kit (Analytik Jena, Jena,
Germany). After elution, 2 ml of product were used in
a TOPO cloning reaction (Invitrogen) following
recommended procedures. XL1-blue competent cells
were transformed with the TOPO reaction and plated
onto LB–50mgml1 kanamycin plates, suplemented
with X-GAL (5-bromo-4-chloro-3-indolyl-beta-D-ga-
lacto-pyranoside). A total of 10 clones were isolated
per animal; plasmid DNA was purified using innu-
PREP Plasmid Mini Kit. Plasmids were sequenced
using standard M13 primers.
Results
In utero GC exposure triggers increased drug-seeking
behavior in adulthood
To test the hypothesis that prenatal GC exposure
would increase drug preference, we compared all
experimental groups in a CPP paradigm. As compared
with controls, iuGC-treated animals developed a
stronger preference for morphine, spending more
time in the compartment previously associated with
morphine reward (Figure 1a; t=4.623, P=0.0036).
Whereas control and iuGC animals did not differ in
their intake of sucrose solution (Supplementary
Figure S1), iuGC animals demonstrated an approxi-
mately two-fold greater preference than controls for
ethanol in a two-bottle free-choice paradigm over a
period of 2 weeks (Figure 1b; t=3.523, P=0.0048). As
locomotor activity is considered to predict suscept-
ibility to drug abuse,1,26 it was interesting to note that
morphine stimulated locomotor activity (open-field
arena) to a greater extent in iuGC animals than in
controls (B160% vs B35%; F(3,15) = 67.94, P<0.0001;
Figure 1c). To exclude the potentially confounding
effects of inadequate maternal care, itself a suspected
etiological factor in stress-related psychiatric disor-
ders,27–29 we analyzed the maternal behavior of
control and GC-treated dams, and also performed a
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cross-fostering experiment. Neither self- nor pup-
directed behaviors were significantly influenced by
GC treatment (Supplementary Figure S2). Identical
behaviors were observed when iuGC offspring raised
by natural and fostered mothers were compared in the
CPP (Figure 1a; t=6.877, P<0.0001) or ethanol
consumption (Figure 1b; t=12.58, P<0.0001) tests.
Although the hypolocomotor profile observed in non-
fostered iuGC animals in the open field test was not
seen in cross-fostered iuGC rats (Figure 1c), morphine
elicited a hyperlocomotor response in both cross-
fostered and non-fostered iuGC animals as compared
with control rats raised by foster mothers (Figure 1c;
t=2.737, P=0.021). Collectively, these findings
indicate that exposure to prenatal GC increases
vulnerability to drug-seeking behavior.
Morphological and neurochemical changes in the
NAcc after in utero GC exposure
Increased sensitivity to the psychomotor-stimulatory
actions of drugs such as morphine reflects increased
DA release into the NAcc.1,26 Furthermore, the
dopaminergic system seems particularly sensitive to
the effects of GCs.5,12,30 Thus, we next assessed
the impact of prenatal GC upon the number of
TH-positive fibers, DA and DA metabolite levels,
as well as DA turnover in the NAcc (Figure 2).
The number of TH-positive fibers in both the core and
shell divisions of the NAcc were significantly
reduced in iuGC animals (Figure 2a, shell: t=2.827,
P=0.022; Figure; core: t=10.48, P<0.0001; Supple-
mentary Figure S3), in parallel with markedly
reduced NAcc levels of DA (t=2.567, P=0.0247)
and the DA metabolite 3,4-dihydroxyphenylacetic
acid (DOPAC; t=2.362, P=0.0376; Figure 2c); inter-
estingly, the levels of norepinephrine and epinephr-
ine, two other catecholamine transmitters whose
synthesis indirectly depends on TH, as well as of
the unrelated monoamine serotonin (5-HT), were not
affected by prenatal GC exposure. Importantly, besi-
des the reduced availability of DA in the NAcc,
iuGC-treated animals also displayed increased DA
turnover (Figure 2d; t=2.835, P=0.0196). Moreover,
as no remarkable neurochemical changes were obser-
ved in the VTA or other DA projection fields (pre-
frontal cortex, hippocampus; data not shown), the
Figure 2 Prenatal glucocorticoid (GC) reorganizes dopaminergic innervation and dendritic structure in the nucleus
accumbens (NAcc). In utero GC-exposed (iuGC) animals presented reduced tyrosine hydroxylase (TH)-positive fibers in the
shell (a) and core (b) subdivisions of the NAcc when adults. (c) High-performance liquid chromatography (HPLC)
measurements confirmed reduced levels of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanilic acid
(HVA) in the NAcc of iuGC animals in comparison with controls in parallel with increased turnover of DA in this brain
region (d). Stereological assessment revealed a volumetric atrophy (e) in the NAcc shell in iuGC animals together with
reduced number of cells (f). We observed no changes in dendritic length (g), but there was an increase in the total number of
spines in the medium spiny neurons of iuGC animals when compared with controls (h), as a result of increased number of
immature spines (i). (j) Representative reconstruction of medium spiny neurons of NAcc shell in control and iuGC animals.
The NAcc core of iuGC animals also presented volumetric atrophy (k) and reduced number of cells (l), but preserved
dendritic length; spine numbers and mature/immature spine ratio (m–o). (p) Representative reconstruction of a medium
spiny neuron from NAcc core in control and iuGC animals. Data is presented as mean±s.e.m. CONT, controls; NE,
norepinephrine; EPI, epinephrine; 5-HT, serotonin. *P<0.05, **P<0.01,*** P<0.001.
Figure 1 Prenatal in utero glucocorticoid (iuGC) exposure enhances drug-seeking behaviors. (a) In the contingent
conditioned place preference paradigm (CPP), iuGC animals spend significantly more time in the morphine-associated
compartment than controls. (b) In the non-contingent two-bottle preference paradigm, total ethanol consumption was higher
in iuGC animals than in controls. Similar results were obtained for cross-fostered animals in both paradigms. (c) Locomotor
activity was assessed in the open field. Although in basal conditions, iuGC animals presented reduced locomotor activity,
after morphine administration (MOR), iuGC rats displayed increased locomotor activity when compared with controls.
Cross-fostered iuGC-animals no longer present the basal hypolocomotor phenotype, but after MOR, they still presented
increased locomotor activity. Data is presented as mean± s.e.m. CONT, controls; MOR, morphine (10mgkg1) s.c. injection.
*P<0.05, **P<0.01,*** P<0.001.
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NAcc is seemingly most sensitive to the effects of
prenatal GC.
Extending our previous finding that prenatal GC
treatment leads to reduced neuronal proliferation in
the NAcc,12 we now report that iuGC results in
volumetric atrophy (Figure 2e, shell: t=4.340,
P=0.0025; Figure 2k, core: t=5.906, P=0.0004) and
a reduction of total cell numbers in both the shell and
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core divisions of the NAcc in iuGC adult animals
(Figure 2f, shell: t=3.018, P=0.0166; Figure 2l, core:
t=3.760, P=0.0055). Subsequent 3D morphological
analysis of dendrites and spines showed that whereas
prenatal GC did not influence dendritic lengths of
neurons in the NAcc (Figure 2g and m), the treatment
produced significant increases in the number of
spines within the shell (Figure 2h; t=3.775,
P=0.0069), but not the core division (Figure 2n).
The increase in spine number was accompanied by a
significant increase in the relative number of im-
mature spines in the shell (Figure 2i; t=3.108,
P=0.017), which, presumably, serve to compensate
for the loss of cells in the NAcc and for the reduced
amounts of DA reaching the NAcc from the VTA.
Notably, although iuGC treatment was associated
with increased total spine numbers in the VTA,
the treatment did not alter the ratio of immature to
mature spines in this region (Supplementary Figure
S4). These morphological data, together with the
neurochemical data described above, suggest a link
between a hypodopaminergic state in the NAcc
and the behavioral phenotype observed in animals
exposed to prenatal GC.
Altered expression of DA receptor 2 (Drd2) is
associated with differential methylation of Drd2 gene
in iuGC-treated animals
We next used quantitative reverse-transcription PCR
and immunoblotting to identify molecules that might
be responsible for the observed behavioral, morpho-
logical and neurochemical phenotypes. Expression
levels of the mRNAs encoding the GC receptor and
corticotropin releasing factor receptors 1 and 2 (all
implicated in the neuroendocrine adaptation to stress
as well as in drug-seeking behavior1), did not differ
between controls and iuGC subjects (Supplementary
Figure S5). Likewise, no significant differences were
found in the expression levels of the synaptic
plasticity-related genes Bdnf, synapsin-1, Cdk5, Creb
and NCAM (Supplementary Figure S5). However,
there was a significant upregulation of Drd2 mRNA
(Figure 3a; t=2.764, P=0.028) and DRD2 protein
(Figures 3b and c; 35 kDa precursor, t=3.740,
P=0.0028; 47kDa isoform, t=3.372, P=0.005; 72 kDa
glycosylated DRD2, t=2.177, P=0.050) in the NAcc of
iuGC animals. Prenatal GC exposure did not influence
either Drd1 or Drd3-5 mRNA expression levels
(Figure 3a) or the levels of DRD1 protein (50 kDa
and glycosylated 74 kDa isoforms; Supplementary
Figure S5). In the VTA of iuGC animals, Drd5 levels
were downregulated (Supplementary Figure S5), but
the expression of other DA receptors was unchanged
(data not shown).
Strikingly, repeated exposure to morphine and
ethanol in prenatal GC-treated adult rats led to a
significant decrease in the expression of Drd2 mRNA
in the NAcc (Figure 3d; morphine: t=2.346, P=0.043;
ethanol: t=3.330, P=0.0021). As recent studies
reported that psychostimulant treatment induces
epigenetic changes in the NAcc,31–33 we next analyzed
the pattern of methylation (strongly correlated with
transcriptional repression) in a conserved (human
and rodent) CpG island within the Drd2 gene, cover-
ing part of the promoter region and exon 1 (Figure 3e).
Our analysis shows that whereas the general DNA
methylation profile did not differ between controls
and iuGC subjects under basal conditions, overall
methylation of the CpG island was significantly
increased after chronic morphine administration in
adult iuGC-treated animals (Figure 3f–h; t=3.085,
P=0.0215). These changes in DNA methylation are
consistent with the finding that Drd2 expression is
downregulated after morphine treatment (Figure 3d).
Further, the observation that voluntary ethanol con-
sumption (Figure 3d) also downregulates Drd2 sug-
gests Drd2 DNA methylation as a potentially
important mechanism in response to substances of
abuse.
Restoration of DA levels reverts the molecular,
cellular and behavioral phenotype of iuGC animals
The results presented up to this point indicate a
strong association between the hypodopaminergic
state that prevails in the NAcc of iuGC-exposed
subjects and their likelihood to seek drugs of abuse.
We next examined whether the phenotype produced
by iuGC could be rescued using a simple pharmaco-
logical approach. To this end, we administered
the DA precursor L-dopa (together with carbidopa
to prevent peripheral degradation) for 3 days. This
treatment regimen resulted in concomitant increases
in DA levels (Figure 4a; F(3,21) = 23.79, P<0.0001)
and correspondingly, decreases in Drd2 expression
(Figure 4c; t=2.982, P=0.038) in the NAcc of
controls and iuGC-treated animals. Interestingly, the
dynamic Drd2 response to morphine was normalized
after restoration of DA in the NAcc by L-dopa treat-
ment, with iuGC-treated and control animals showing
similar patterns of Drd2mRNA expression (Figure 4c)
and Drd2 promoter methylation (Figure 4d–f). Inter-
estingly, the neurochemical adjustments induced
by L-dopa were accompanied by signs of structural
plasticity in the NAcc. These were particularly
marked in the core division of the NAcc, where
L-dopa-treated animals displayed increased den-
dritic lengths (more pronounced in iuGC-exposed
animals; Figure 4j; F(3,12) = 4.587, P=0.023) and
spine numbers (Figure 4k; F(3,12) = 10.01, P=0.0014),
though the type of spines were similar between the
two groups (Figure 4l). In contrast, increased spine
numbers was the only noticable morphological
change observed in the NAcc shell (Figure 4h;
F(3,10) = 14.86, P=0.0005).
Remarkably, acute (3 days) L-dopa treatment also
reversed the vulnerability of iuGC-exposed animals to
drug-seeking behaviors, in both contingent (t=1.851,
P=0.101) and non-contingent (t=0.0192, P=0.985)
paradigms (Figures 4m and n), and rescued the
hyperlocomotor phenotype displayed by iuGC-treated
animals after morphine administration (Figure 4o;
t=2.292, P=0.05). Reversal of these behaviors by
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acute L-dopa administration however proved to be
only transient; the reversal was not sustained when
animals were tested 3 weeks after the last dose of
L-dopa (Supplementary Figure S6). On the other
hand, when the L-dopa treatment regimen was exten-
ded to 3 weeks, reversal of the behavioral, morpho-
logical and molecular anomalies associated with
a hypodopaminergic state was observable for at
least 3 weeks after discontinuation of the drug
(Supplementary Figure S6).
Discussion
Work over the last two decades has identified the
dopaminergic mesolimbic ‘reward pathway,’ of which
the NAcc is a crucial component, as essential for
drug-seeking behaviors.13,14,34,35 The central role of DA
released into the NAcc in the generation of enhanced
feelings of pleasure and satisfaction15 and, thus, in
the timing of the initiation of response patterns (e.g.,
drug-seeking behavior) within the frontocortico-
Figure 3 Impaired dopamine receptor 2 (Drd2) response in in utero glucocorticoid-exposed (iuGC) animals under basal
conditions and after exposure to substances of abuse. (a) Drd2 mRNA expression was augmented in iuGC animals when
compared with controls, but no changes were found in the expression of other dopamine receptors. (b) Representative
immunoblot of DRD2 in five control and five iuGC animals. The levels of the putative DRD2 percursor (35 kDa), the non-
glycosylated form (B50 kDa) and the glycosylated receptor (74 kDa) were higher in iuGC animals (c). (d) Although in a basal
situation, Drd2was upregulated in iuGC animals, after four injections of morphine (MOR) or 15 days of ethanol consumption
(EC), the levels of this receptor were significantly lower in iuGC animals when compared with controls. (e) Scheme of the rat
Drd2 CpG island that covers part of the promoter, and exon 1 and respective amplicon with the 16 potential methylation sites
are marked (small squares). Also shown is the sequence conservation in humans and mouse (chr8: rat chromosome 8; bp:
base pairs). (f) Percentage of total Drd2 CpG methylation in the NAcc of control and iuGC animals revealed a trend for a
reduction in the methylation pattern of Drd2 CpG island in basal conditions, but in opposite pattern after exposure to
morphine. (g) Percentage of methylation of each dinucleotide in the Drd2 CpG island in a basal situation. (h) After drug
exposure, iuGC animals presented an increase in the methylation status of several dinucleotides. Data is presented as
mean±s.d. CONT, controls; *P<0.05, **P<0.01.
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striatal loop,36 is well established. Current views
suggest that repetitive exposure to drugs of abuse
evolve from goal-directed behaviors into habit-based
actions.37,38 We previously demonstrated that stress,
associated with increased GC secretion, alters the
structure of the corticostriatal loops and steers the
development of instrumental behavior into habitual
behavior.39 The present demonstration of GC-induced
programming of the structure and function of the
NAcc provide, on the other hand, new insights into
the mechanisms that underlie the transfer of condi-
tioned behavior to instrumental behavior. Notably, the
NAcc (the core in particular) is a crucial deter-
minant of the efficiency of response-outcome
associative learning40 and thus, of the rewarding
effects of drugs of abuse;34 the NAcc modulates
motivational drive (‘wanting of a reward’) and thus,
drug-craving. In all these processes, DA seems to have
an essential role.
An intricate relationship between stress, the GC
released in response to stress, and dopaminergic tone
in the regulation of vulnerability to drug and
substance abuse has been suggested.1,5,14,26,41 Stress
and drugs of abuse appear to activate dopaminergic
synapses in a similar manner,41 culminating in DA
release in the NAcc.1,4,42 Stress induces sensitization
to the psychomotor effects of a number of drugs of
abuse and GC have been shown to have an essential
role in this process.1 Specifically, GC are known to
modulate the reinforcing properties of drugs and, in
fact, have positive reinforcing properties of their
own.43 Adding a new perspective, the present study
demonstrates that iuGC triggers an impoverishment in
dopaminergic inputs and DA levels in the NAcc,
leading to increased drug-seeking behavior in adult-
hood; notably, hypodopaminergic status is a hallmark
of the ‘addicted brain.’44,45 Associated with their
lower intra-NAcc levels of DA, animals exposed to
prenatal GC expressed more Drd2 in the NAcc,
potentially indicating a compensatory mechanism in
this structure. The finding that morphine and ethanol
downregulated Drd2 expression is consistent with the
DA-releasing abilities of these substances. The fact
that this downregulation is more pronounced in iuGC
subjects most likely reflects receptor hypersensitivity
due to the hypodopaminergic state previously in-
duced by iuGC.
The regulation of Drd2, implicated in different
phases of addiction, is seemingly complex;44 although
the short DRD2 isoform interacts with DA transporters
and functions as a presynaptic autoreceptor to
regulate dopaminergic tone, the long DRD2 isoform
is largely localized in postsynaptic targets and
mediates the effects of psychostimulants.46 The
present study reveals that vulnerability to substance
abuse depends on the dynamic range response of
Drd2 to increased DA release in the NAcc, rather than
simply on the expression of Drd2 at a given time
point. Such dynamic regulation is likely to depend on
different levels of transcriptional control.
Epigenetic mechanisms are being increasingly im-
plicated in the stable programming by early life
events of a spectrum of psychopathological states,
including anxiety and depression,29 impaired cogni-
tion47 and drug abuse,31–33,48,49 and transient epige-
netic modifications have been shown to underlie
neural processes such as learning and memory.50
Such epigenetic changes could imprint dynamic
environmental experiences on the unchanging gen-
ome, resulting in stable and adaptive alterations in
the phenotype. Our results demonstrate that exposure
to high GC levels during uterine development
increase the risk of drug-seeking behavior in associa-
tion with altered methylation status of a conserved
CpG island in Drd2 gene and therefore, interfering
with the dynamics of Drd2 expression. Further, they
show that repeated administration of morphine to
iuGC animals results in marked epigenetic modifica-
tions of the Drd2 gene promoter. These modifications,
together with the induced hypodopaminergic state in
iuGC-exposed animals, may be considered as key
mechanisms that underpin increased susceptibility to
drug abuse on one hand, and the dysregulated Drd2
response to drugs of abuse on the other.
Intriguingly, we found that reduced levels of Drd2
expression are not necessarily coupled to hyper-
methylation of Drd2 gene. Although Drd2 expression
was downregulated after morphine administration in
Figure 4 Restoration of dopamine (DA) levels by L-dopa reverts the molecular, structural and behavioral phenotypes of
in utero glucocorticoid (iuGC) animals. (a) Acute (3 days) treatment with L-dopa increased DA levels in the nucleus
accumbens (NAcc) of both experimental groups; although iuGC animals still exhibited less DA than controls. In fact, iuGC
animals given L-dopa presented DA levels similar to those of controls without treatment. (b) No differences were found in DA
turnover after L-dopa treatment in iuGC animals. (c) Dopamine receptor 2 (Drd2) expression was diminished after L-dopa
treatment both in a basal situation and after morphine exposure (values normalized to controls given water). (d) L-dopa
treatment did not change Drd2 methylation status in a basal situation (e), but was able to revert the increased methylation in
iuGC animals after morphine exposure (f). L-dopa supplementation had no significant effect on NAcc shell dendritic length
(g), but triggered an increase in the number of spines, albeit similarly in control and iuGC animals, and reverted the altered
ratio of mature to immature spines observed in iuGC animals (h and i). (j) In contrast, L-dopa treatment increased dendritic
length in the NAcc core of both groups. An increase in the number of spines was also observed in both groups with no
changes in the type of spines (k and l). (m) L-dopa treatment reverted the higher vulnerability of iuGC animals to morphine-
induced CPP and also reverted the ethanol preference displayed by these animals (n). (o) In agreement, the higher locomotor
pattern after morphine displayed by iuGC rats was completely reverted by L-dopa treatment. No differences were found in
the locomotion between L-dopa treated control and iuGC animals in a basal situation. Data is presented as mean±s.e.m.
CONT, controls; MOR, after morphine injection 10mgkg1; 3d: 3 days; *P<0.05, **P<0.01,***P<0.001.
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both control and iuGC animals, Drd2methylation was
observed to a greater extent in the iuGC group. This
observation suggests that DNA methylation is not the
sole mechanism involved in transcriptional repres-
sion of Drd2 gene. Consistent with this, recent studies
have demonstrated interdependence and cooperation
between DNA methylation and histone modifications
in the regulation of gene silencing and activation.51
More extensive studies are needed to decipher the
precise mechanisms underlying the ‘epigenetic po-
tential’ of iuGC animals, namely the complex regula-
tion of Drd2 gene expression, which facilitates
adaptation to specific physiological states and
demands.
In exploring whether the dynamic epigenetic
mechanisms that regulate susceptibility to drug-
seeking behavior can be exploited in a therapeutic
context, we found that systemic administration of
L-dopa reverts drug-seeking behavior in iuGC-treated
animals. The latter occured in association with
morphological plasticity and significant decreases in
Drdr2 expression levels in the NAcc. Accordingly, we
suggest that susceptibility to drug-seeking behavior by
iuGC exposure results from the sequential depletion
of DA, upregulation of Drd2 and synaptic impover-
ishment of dopaminoceptive neurons in the NAcc
(Supplementary Figure S7). In this scenario, when
DA levels are stimulated by substances of abuse,
increased methylation of the Drd2 gene results in
downregulation of Drd2 expression albeit only in
iuGC animals. Strikingly, restoration of DA in the
NAcc of iuGC-treated animals also normalizes their
Drd2 responses to subsequent morphine and ethanol
exposure, a finding that most likely underlies the
above-mentioned reversion of drug-seeking behavior.
If translatable to humans, our findings suggest that a
simple reinstatement of dopaminergic homeostasis
may be sufficient to control addictive behaviors in
vulnerable individuals.
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